Skip to content

The effects of an electronic Health (e-Health) intervention for people with hyperlipidaemia to reduce their cardiovascular risk: A randomised controlled trial

The effects of an electronic Health (e-Health) intervention for people with hyperlipidaemia to reduce their cardiovascular risk: A randomised controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260630002
Enrollment
120
Registered
2026-06-30
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidaemia Elevated LDL-C Cardiovascular risk Hyperlipidemias Cardiovascular Diseases Health Education eHealth Mobile Health mHealth Lipids Heart Disease Risk Factors

Interventions

Participants in the intervention group will have access to the e-Health mobile application(The App). The App was designed to convey relevant health information for educational purposes, provide additi
Experimental Behavioral,No Intervention No treatment
Intervention group,Control group

Sponsors

The University of Auckland
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. People who were diagnosed with hyperlipidaemia. 2. Aged between 30 and 60 years, as this age range is most likely to have low to moderate CV risk profiles. 3. LDL-C levels 100-190 mg/dl and not requiring lipid-lowering medications. 4. No prior use of lipid-lowering medication for hypercholesterolemia. 5. Have access to and be able to use their own smartphones to participate in the study, download the app, complete the survey questions, upload data and be available for follow-up. 6. Require a scheduled blood test at baseline and at 6 months for routine clinical management. 7. Have had no previous CV event or diagnosis of coronary heart disease. 8. Have no familial hypercholesterolemia. 9. Have no serious chronic condition likely to affect participation in the trial (i.e. cancer, chronic kidney disease or advanced chronic pulmonary obstructive disease) which might necessitate hospitalisation during the study.

Exclusion criteria

Exclusion criteria: 1. Participation in other research that may affect health behaviours, blood lipid levels, or the outcomes of this study during the same period

Design outcomes

Primary

MeasureTime frame
Lipid profiles at 6 months end of the intervention Standardized laboratory,Blood pressure at 6 months end of the intervention Automated blood pressure monitor,Thai CV risk score at 6 months end of the intervention web-based Thai CV Risk Score calculator

Secondary

MeasureTime frame
Nutrition behavior at 1,3, and 6 months Cardiovascular dietary questionnaire,Physical activity at 1,3, and 6 months Thai version of short format International Physical Activity Questionnaire (Thai short IPAQ),Smoking cessation at 1,3, and 6 months Glover Nilsson Smoking Behavioral Questionnaire,Knowledge and health literacy at 1,3, and 6 months Heart Disease Knowledge Questionnaire,Body Mass Index at 6 months end of the intervention Using standard equipment BMI calculated,HbA1c at 6 months end of the intervention Standardized laboratory,Waist circumference at 6 months end of the intervention A non stretch measuring tape,App usability at 1, and 3 months The mHealth App Usability Questionnaire,Smoking status at 6 months end of the intervention Health Record Form

Countries

New Zealand

Contacts

Public ContactWarisa Kanbuala

The University of Auckland

warisa.kanbuala@auckland.ac.nz668688459

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026